–
Acrivon Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−16.2
FY22:
−32.7
FY23:
−67.1
FY24:
−89.2
FY25:
−84.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−16.1
FY22:
−32.3
FY23:
−66.6
FY24:
−88.2
FY25:
−82.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−16.2
FY22:
−31.2
FY23:
−60.4
FY24:
−80.4
FY25:
−77.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−16.2
FY22:
−31.2
FY23:
−60.4
FY24:
−80.6
FY25:
−77.9
All amounts in millions USD